DK
David Kirn
See Remarks

David Kirn insider trades: 4D Molecular Therapeutics (FDMT) stock sales

See Remarks, 4D Molecular Therapeutics Last trade Oct 5, 2026 22 Form 4 filings
$5.0M
Sold, last 12 months
8 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 5, 2026FDMT↓ Sell$754K
Sep 14, 2026FDMT↓ Sell$811K
Aug 19, 2026FDMT↓ Sell$1.1M
Aug 4, 2026FDMT↓ Sell$275K
Aug 3, 2026FDMT↓ Sell$125K
Jul 10, 2026FDMT↓ Sell$737K
Jun 22, 2026FDMT↓ Sell$1.2M
Jun 1, 2026FDMT↓ Sell$19K
Jul 10, 2024FDMT↓ Sell$291K
Jun 24, 2024FDMT↓ Sell$299K
Feb 8, 2024FDMT↓ Sell$2.5M
Jan 23, 2024FDMT↓ Sell$105K
Jan 5, 2024FDMT↓ Sell$2.0M
Feb 22, 2023FDMT↓ Sell$710K
Jan 20, 2023FDMT↓ Sell$392K
Dec 16, 2022FDMT↓ Sell$2.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other FDMT insiders

Open-market trades in the last 12 months

About David Kirn's insider trades

David Kirn is See Remarks at 4D Molecular Therapeutics (FDMT). Since Dec 16, 2022, David has reported no open-market purchases and 16 sales worth $13.3M on SEC Form 4. In the last 12 months: 8 sales ($5.0M).

Their filings also include grants and awards (5 filings), option exercises (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FDMT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.